German industry opposes BfArM role in medtech clinical trials approvals
This article was originally published in Clinica
Executive Summary
German medical device companies are coming out in opposition to a provision in the draft medical device law revision (MPG4) that requests companies conducting clinical trials to obtain approval for device trials from the competent authority.